Human anti-La/SS-B autoantibodies are known to react with highly conserved epitopes suggested to be functional or active sites on the La/SS-B polypeptide. This study was designed to determine whether the autoantibodies also react with poorly conserved regions of La/SS-B as predicted by an antigendriven autoimmune response. Binding of human autoantibodies to purified human, mouse, and bovine recombinant fragments representing immunodominant regions of the La/SS-B polypeptide was compared using Western blotting and ELISA. A cross-reactive epitope was located in the highly conserved NH2-terminal region of La/SS-B. Significantly, human-specific epitopes were identified in both the conserved RNA-recognition motif and a poorly conserved COOH-terminal fragment, providing direct evidence for an autoantigen-driven response. The lack of autoantibody cross-reactivity with a conserved domain of mouse and bovine La/ SS-B implies that a small number of residues in human autoepitopes may be critical for autoimmunogenicity. (J. Clin. Invest. 1993Invest. . 92:1104Invest. -1108
Introduction
In autoimmune diseases such as Sjogren's syndrome or SLE, the human B cell response to the La/SS-B autoantigen is directed to multiple epitopes that span the full length of the La/ SS-B polypeptide (1) (2) (3) (4) (5) (6) (7) . An immunodominant, discontinuous epitope has been identified at the NH2 terminus (LaA; amino acids [aa ]' -107) and may be recognized early in the response (8) . The majority of anti-La/SS-B sera also react with a putative RNA-recognition motif( RRM; aa 112-187) located in the middle region of the molecule (LaC; aa 11 (1, 7) . The RRM and an NH2-terminal flanking region appear to be necessary for binding to a short sequence ofuridylate residues at the 3' terminus of small RNAs (mostly RNA polymerase III transcripts) to form a ribonucleoprotein complex (9, 10) . The majority of sera also react with a COOH-terminal epitope (LaL2/ 3; aa 346-408) that may be recruited later in the anti-La/SS-B response (7) . The IgG autoantibodies are present in high serum concentrations (11 ) and are associated with particular MHC class II alleles ( 12) . The above observations constitute indirect evidence for an antigen-driven mechanism of autoantibody production.
The broad cross-reactivity of human anti-La/SS-B sera with La/SS-B antigen from diverse mammalian species indicates the presence of conserved epitopes ( 13 ) . Antigenicity of conserved structural elements has been noted as a general rule for nuclear autoantigens ( 14) . Taken together with the observation that many autoantibodies appear capable of inhibiting the cellular functions served by the autoantigens (reviewed in 15), it has been proposed that the anti-La/SS-B response targets highly conserved epitopes that correspond to functional domains of the molecule ( 13) . This pattern of autoantibody specificity contrasts with the species-specific epitopes recognized after immunization with La/SS-B protein (13 
Methods
Derivation and expression ofmouse and bovine DNA encoding La/SS-B fragments. Fig. 1 shows alignment of the human and mouse LaA, LaC, LaL2/3, and RRM regions. The bovine RRM sequence is included in the boxed RRM region. Alignment was configured using the FAST.P align program ( 17) . Four DNA fragments encoding nonoverlapping subregions of the mouse La/SS-B coding sequence were derived by PCR ( 18 
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346 360 La/SS-B cDNA sequence to correspond to the previously defined fragments LaA, LaC, LaL2/3 and the RRM on human La/SS-B, with the addition ofa BamHI site and an EcoRI site on the 5'and 3' oligonucleotides, respectively. The amplification was performed for 25 cycles, with each cycle comprising 1 min at 95°C, 2 min at 55°C, and 3 min at 72°C. Each mouse La/SS-B DNA fragment was subcloned into the pGEX-2 vector, sequenced to confirm in-frame gene fusions and absence ofamplification errors as described (7), and expressed as a glutathione-S-transferase (GST) fusion protein. The recombinant proteins were purified from the soluble fraction of lysates of Escherichia coli strain LE 392 transformants prepared with 1% Triton X-100. The mouse LaC insert was subcloned into the pQE-9 vector (QIAGEN Inc., Chatsworth, CA), expressed as an in-frame hexa-his-fusion protein with six histidines at the NH2-terminus, and purified as described ( 19). A PCR DNA fragment encoding the bovine RRM (aa 111-187) was derived from a bovine La/SS-B cDNA (20) (a gift from Dr. Edward Chan, The Scripps Research Institute, La Jolla, CA), subcloned into the pGEX vector and the GST-fusion protein purified as above. Western blotting. Human and mouse La/SS-B-GST-fusion proteins were separated on 12.5% SDS-polyacrylamide gels and transferred to nitrocellulose membrane (Bio-Rad Laboratories, Richmond, CA). After transfer, the remaining protein binding sites were blocked for 1 h at room temperature with a solution of 5% nonfat dried milk powder in PBS (0.05 M sodium phosphate, 0.15 M NaCl, pH 7.4). The nitrocellulose was probed with a 1:3,000 dilution of either a polyclonal rabbit anti-GST serum or a pool of 18 anti-La/SS-B precipitin-positive human sera, and binding of the antisera visualized with a horseradish peroxidase-conjugated sheep anti-rabbit or rabbit anti-human IgG (Silenus Labs. Pty, Ltd., Melbourne, Australia) and enhanced chemiluminescence (Amersham International, Amersham, UK).
ELISA. Binding ofhuman anti La/ SS-B sera (diluted 1:500) to the recombinant human and mouse La/SS-B fusion proteins was determined by ELISA as previously described with coating concentrations chosen to give equivalent OD405nm readings with the rabbit anti-GST serum (8, 21 rabbit anti-GST serum (Fig. 2 A) . The eight recombinant La/ SS-B proteins were of the expected molecular weight by gel electrophoresis. Bands corresponding to proteins of lower M, were presumed to represent degradation products (7) . A representative Western blot of the human and mouse recombinant La/SS-B proteins probed with the pooled human anti-La/SS-B sera is shown in Fig. 2 ern blots were probed with 1:100 and 1:1,000 dilutions ofantiserum (data not shown). No reactivity was noted with a hexahis-mouse LaC fusion protein expressed in the pQE vector, indicating that the lack of reactivity with GST mouse LaC was not due to a masking effect of the GST moiety (data not shown). Fig. 3 shows a representative immunoblot of GST fusion proteins encompassing the human, bovine, and mouse RRM probed with the anti-GST (A) and human anti-La/ SS-B (B) sera. The human antisera were strongly positive on immunoblots of the human RRM but failed to react with either the bovine or mouse RRM-GST proteins. Control sera did not react with any of the RRM-GST proteins (data not shown).
Binding to the different human and mouse La/SS-B polypeptides by the pooled human anti-La/SS-B sera and by sera from the individual patients was then tested on ELISA (Table  I) . These data confirm the results ofthe Western blot analysis, with the human antisera reacting with the intact polypeptide (Table II) .
Discussion
A comparison of the primary sequence of human and mouse La/SS-B reveals that the NH2-terminal region containing the LaA epitope is highly conserved and that most interspecies divergence occurs in the COOH-terminal region, which contains the human LaL2/3 epitope (Fig. 1) . This region was predicted to be the most likely site for preferential binding of anti-La/SS-B autoantibodies to the human autoantigen. Sequence divergence within the COOH-terminal halfofthe mole- Table II The confirmation of a human-specific epitope in the poorly conserved COOH-terminal region implies that autoantibodies to the LaL2/3 epitope are generated by autoimmunization. The antibody binding studies described here also define a conserved NH2-terminal epitope (LaA). The LaA epitope has been shown previously to be discontinuous (8) , suggesting that the B cell response to this region is driven by the native autoantigen and is unlikely to arise by molecular mimicry with a linear sequence of a viral gag polypeptide (6) . The lack ofcross-reactivity ofhuman anti-La/ SS-B autoantibodies with the mouse and bovine RRM was unexpected because ofthe highly conserved nature ofthis region ofthe molecule. This observation further underlines the role of self-immunization and reinforces the notion that species-specific epitopes may be targeted in the autoimmune B cell response to nuclear autoantigens (22) (23) (24) . The RRM contains nine amino acid substitutions that distinguish the human and mouse (Fig.  I B) . The absence of reactivity with the bovine RRM identifies a glutamic acid at position 177, an aspartic acid at position 186, and a valine at position 156 as being specific for the human RRM (Fig. 1 B) . These residues are therefore ofcritical importance in controlling recognition of this immunodominant determinant. Analysis of autoantibody binding to deletion mutants ofthe human RRM suggests that as for LaA (8) the dominant epitope in this region is discontinuous (25) . It has been shown recently that binding of antibody to an epitope present on a folded protein can be reduced or eliminated by changing single residues (26) . The same phenomenon is likely to be true for the species-specific component of the B cell response to autoepitopes of La/SS-B and other nuclear autoantigens.
Our results show that the anti-La/SS-B response is characterized by a breakdown in B cell tolerance to both conserved and poorly conserved regions of La/SS-B. Sera from precipitin-negative patients show a restricted B cell epitope pattern with sparing of the poorly conserved COOH-terminal epitope (21) . If the precipitin-negative patient group represents an early oligoclonal response to La/SS-B, then it might be inferred that antibody reactivity is directed initially to conserved epitopes on the autoantigen, with recruitment of less conserved epitopes as the autoimmune response becomes polyclonal and involves the whole molecule. Further studies, including longitudinal analysis of precipitin-negative patients and the use of animal models, will help clarify the questions of hierarchy and dominance of the autoepitopes of La/SS-B.
